BDBetül Diler Durgut

Betül Diler Durgut

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Betül Diler Durgut has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Age-dependent diagnostic performance of mid-upper arm circumference Z-score in pediatric neurology: A multicenter study with a cerebral palsy subgroup

    by Beril Dilber, Burcu Parıltan Küçükali̇oğlu, Hasan Emral, Ali Cansu, Sevim Şahin, Emine Tekin, Betül Di̇lEr Durgut, Pınar Özkan Kart, Fatma Hanci, Gülnur Esenülkü, et al.


  • A case of Joubert Syndrome and NPC1 mutation in a 7-year-old girl: presented with neuromotor developmental delay and ataxia

    by B. Diler Durgut, A. Türkyılmaz

    Niemann-Pick Disease Type C (NPC) is a rare autosomal recessive lipid storage disorder characterized by cholesterol accumulation in lysosomes due to mutations in the NPC1 or NPC2 genes. NPC1 gene m...

  • Bayılma Şikayetiyle Gelen Hastaların Sosyodemografik ve Etiyolojik Değerlendirilmesi: Tek Merkez, Prospektif, Kesitsel Çalışma

    by Betül Diler Durgut, Emine Tekin, Bekir Yukcu

    Amaç: Bu prospektif, kesitsel çalışma, bayılma şikayetiyle pediatrik nöroloji polikliniğine başvuran çocukların sosyodemografik özelliklerini, kronik hastalıklarını, psikiyatrik ve fiziksel durumlarını, ayrıntılı klinik öykülerini ve nihai tanılarını değerlendirmeyi amaçlamıştır. Gereç ve Yöntemler: Nisan 2023 - Nisan 2024 tarihleri arasında pediatrik nöroloji polikliniğine bayılma şikayetiyle başvuran 2-18 yaş arası hastalar çalışmaya dahil edilmiştir. Veri, sosyodemografik bilgiler, aile öyküsü, senkopun klinik özellikleri (sıklık, süre, tetikleyiciler), nörolojik ve kardiyak öyküler, klinik muayene bulguları, elektroensefalogram, laboratuvar test sonuçları ve tetkiklerden elde edilmiştir. Birden fazla senkop atağı geçiren veya ek kardiyak semptomu bulunan hastalar kardiyolojiye yönlendirilmiştir. Bulgular: Çalışmaya toplam 125 hasta dahil edildi. Bu hastalardan 3'ü epilepsi, 1'i kardiyojenik senkop, 101'i ise vazovagal senkop tanısı aldı. Etiyoloji 20 hastada belirlenemedi. Hastaların çoğunluğu (%64) kız cinsiyette ve 10-15 yaş aralığındaydı. Kronik hastalıklar hastaların %19,2'sinde ve psikiyatrik bozukluklar %7,2'sinde tespit edildi. Sekiz hastada B12 vitamini eksikliği, 63 hastada ise D vitamini eksikliği saptandı. Senkop öncesi en sık gözlemlenen belirtiler baş dönmesi (74,4%) ve fenalaşma hissi (62,4%) iken, senkop sonrası bulgular arasında kasılma/titreme (34,4%) ve kusma (9,6%) yaygın olarak bildirildi. Sonuç: Bu çalışma, pediatrik senkop vakalarının çoğunun iyi huylu olduğunu ve en yaygın nedenin vazovagal senkop olduğunu göstermektedir. Az sayıda hastada kardiyojenik senkop gibi ciddi altta yatan durumlar ve epilepsi gibi senkopla karışabilecek hastalıklar da tespit edilmiştir. Senkop etiyolojisinin belirlenmesinde, klinik öykü, fiziksel muayene ve gerektiğinde uygun testlerin yapılması büyük önem taşımaktadır.

  • Open Access

    Brain magnetic resonance imaging findings and their relationship with prognosis in children with focal epileptic encephalographic discharges

    by Betül Diler Durgut, Tülay Kamaşak, Sibel Kul, Elif Acar Arslan, Sevim Şahin, Beril Dilber, Ali Cansu

    Objective: This study aimed to evaluate the relationship between normal brain magnetic resonance imaging (MRI) findings and prognosis in children with focal epileptic disorder on electroencephalography (EEG) without an epileptic syndrome. Material and Methods: Data from patients aged 0-18 years, who were followed up with a diagnosis of epilepsy at the pediatric neurology clinics over the last 5 years, were retrospectively reviewed. Patients with focal epileptic disorder on EEG were selected. Those with an epileptic syndrome were excluded from the study. The patients’ demographic characteristics, seizure types, etiologies, brain MRI findings, seizure focus, treatment methods, and seizure control were analyzed. Patients were divided into two groups based on their brain MRI findings (normal and abnormal) and compared in terms of treatment resistance, number of medications, and seizure control. Results: The mean age of the 100 patients included in the study was 8±4.32 years, with an equal gender distribution (50% female, 50% male). Generalized seizures were observed in 72% of patients, while 28% had focal seizures. Seizure freedom was achieved in 60% of cases, and treatment resistance was noted in 23%. Cranial MRI revealed structural abnormalities in 67% of patients, with the majority (84%) showing sequelae-related changes, including hypoxic-ischemic sequelae (16%), encephalomalacia (12%), and structural malformations (10%). Although treatment resistance (28.8% vs. 12.1%) was higher and seizure freedom (56.7% vs. 66.7%) was lower in patients with abnormal MRI findings compared to those with normal MRI, these differences were not statistically significant (p =0.150 and p=0.310 respectively) . However, perinatal (p=0.013) and postnatal complications (p=0.042) were significantly more frequent in patients with abnormal MRI findings. Conclusion: In children with focal epileptic disorder on EEG, normal brain MRI findings do not predict a better prognosis in terms of seizure control and treatment resistance. Other factors affecting treatment resistance in this population need to be investigated in more detail.

  • Open Access

    Evaluation of Heart Rate Variability in Children Presenting with Syncope

    by Bekir Yukcu, Betül Diler Durgut, Emine Tekin, Fidel Ceren Yavuzyilmaz

    Objective: This study evaluated the diagnostic value of heart rate variability (HRV) parameters obtained from 24-hour Holter monitoring in pediatric patients with vasovagal syncope (VVS) and compared them to a control group. The study also analyzed time-domain and frequency-domain HRV parameters to explore the autonomic mechanisms underlying VVS and the diagnostic potential of HRV. Methods: This retrospective study was conducted at *** Women’s and Children’s Health Training and Research Hospital. Forty-one children with VVS and 36 healthy controls undergoing 24-hour Holter monitoring for ventricular extrasystoles were included. Comprehensive cardiac, neurological, and demographic evaluations were performed for all participants. HRV parameters were analyzed from 24-hour Holter recordings, and group comparisons were performed using the Mann–Whitney U test. Spearman correlation and Receiver Operating Characteristic analyses were also conducted. Results: Time-domain HRV parameters were significantly lower in the syncope group compared to those in the control group (p < 0.05). No significant differences were observed in frequency-domain parameters. The standard deviation of normal-to-normal RR intervals (SDNN) demonstrated the highest diagnostic accuracy, with a cut-off value of

  • Effects of antiseizure drugs zonisamide, oxcarbazepine, clobazam, and lacosamide on FOXO1, LIF, and E-cadherin- mediated molecules in rat embryo implantation

    by Betül Diler Durgut, Pınar Özkan Kart, Hayrunnisa Yeşil Sarsmaz, Seren Gülşen Gürgen, Ali Cansu

  • The relationship between ghrelin, epilepsy-related inflammatory biomarkers (IL-1β, IL-1R1, HMGB1), and drug-resistant epilepsy in children

    by Betül Diler Durgut, Beril Dilber, Tülay Kamaşak, Hüseyin Yaman, Ömer Faruk Saz, Cevriye Ceyda Kolaylı, Pınar Özkan Kart, Sevim Şahin, Ali Cansu


  • Open Access

    Clinical Findings and Outcome of Moyamoya Disease/Syndrome

    by Betül Diler Durgut, Beril Dilber, Tulay Kamasak, Ahmet Sarı, Ali Cansu

    Objective: Moyamoya disease is a rare progressive cerebrovascular disorder. It is characterized by progressive stenosis in the terminal branches of the internal carotid arteries, leading to the formation of an abnormal vascular network. The aim of this study was to present the clinical findings and outcomes of pediatric patients diagnosed with Moyamoya disease by analyzing our cohort to identify the common clinical presentations, diagnostic challenges, and treatment outcomes associated with this rare cerebrovascular disorder. Material and Methods: Nine pediatric cases of Moyamoya disease admitted over a 10-year period were retrospectively reviewed. Clinical presentations, associated diseases, radiological findings, treatments, and outcomes were analyzed. Results: The median age at diagnosis was 48 months (3-87). Presenting symptoms included hemiparesis in five patients, seizures in six patients, headache in one patient, and choreathetosis with headache in one patient. Three patients experienced symptoms triggered by fever, and one patient by exposure to hot water. Seven patients presented with ischemic symptoms, while two presented with non-ischemic symptoms. Neurofibromatosis type-1 (NF-1) was associated with the disease in four patients. Recurrent attacks occurred in two patients. Interictal electroencephalograms (EEGs) showed hemispheric/focal slowing in five cases. Cranial magnetic resonance imaging (MRI) revealed infarctions in seven patients, and MR angiography showed bilateral findings in six patients. Two patients experienced no long-term sequelae. Conclusion: Moyamoya disease manifests with both ischemic and non-ischemic symptoms. Recognition of non-ischemic presentations requires a high index of suspicion for accurate diagnosis.

  • Neurologic Disease and Vitamin B 12 Levels in Children

    by Betül Diler Durgut

    Introduction: Vitamin B 12 deficiency is a well-known cause of neurologic symptoms, prompting routine measurement in patients with neurologic conditions. However, elevated B 12 levels are also observed in some cases. Recent studies suggest a potential link between high B 12 levels and neurologic or neurodevelopmental disorders. This study aims to evaluate vitamin B 12 levels in children with neurologic disorders compared with those in general pediatric populations. Materials and Methods: This single-center retrospective study analyzed pediatric patients’ vitamin B 12 levels between 2000 and 2023. Exclusion criteria included incomplete data and vitamin supplementation. Patients were grouped based on B 12 levels ( 1000 pg/mL). Age, gender, and diagnoses were assessed, focusing on patients with elevated B 12 levels (>660 pg/mL) in the neurology clinic. Vitamin B 12 levels were measured using Roche Cobas e 601 analyzers. Results: Over 3 years, 4142 pediatric clinic and 2638 pediatric neurology patients were reviewed. Elevated B 12 levels were more frequent in the neurology clinic. Patients with elevated B 12 levels (n = 338) had a mean age of 8.67 months and a mean B 12 level of 894.7 pg/mL. Of 137 patients with follow-up B 12 measurements, 40.1% normalized, while 17.5% remained > 1000 pg/mL. The most common diagnosis in patients with persistently high B 12 levels was epilepsy, followed by prematurity, cerebral palsy, autism, intellectual disability, and language delay. Conclusions: Elevated vitamin B 12 levels were associated with pediatric neurologic disorders, particularly epilepsy. Further research is needed to clarify the mechanisms and clinical implications of this finding.


  • Sedation with chloral hydrate and melatonin in childhood electroencephalography

    by Betül Diler Durgut, Emine Tekin

    Objective: Recording an electroencephalography (EEG) in children is challenging due to their restlessness during the procedure and inability to follow the required instructions. Sleep deprivation and the use of sedative agents are necessary to perform the recording. This study aims to compare the success of sedation with chloral hydrate and melatonin. Methods: Patients who underwent EEG recording between December 2023 and March 2024 were retrospectively evaluated. The chloral hydrate and melatonin groups were formed for the patients requiring sedation. According to the protocol applied in our clinic, chloral hydrate was administered orally at a dose range of 30-50 mg/kg (max 1500 mg), while melatonin was given orally at a dose of 1-3 mg. The sociodemographic information of the patients was recorded from hospital charts, sleeping rates and EEG recording duration were compared. Results: Of the 471 patients EEG performed, 240 (51%) were female and 231 (49%) were male. The mean age was 9.1±5.1 years, with a median age of 9.5 years. Sleep deprivation was appropriately carried out in 434 patients (92.3%), while 37 patients did not achieved sleep deprivation. Among the 76 patients who received sedation, chloral hydrate was used in 45 (59.2%) and melatonin in 31 (40.8%). Sleeping ratio were 82.2% and 80.6% in the chloral hydrate and melatonin groups respectively; there was no statistically significant difference in sleeping rates (p: 0.86). No serious drug-related side effects were observed in either group. Rare gastric complaints, such as gastric discomfort and nausea/vomiting were noted in the chloral hydrate group. Conclusion: Melatonin and chloral hydrate provided similar rates of sedation. This study showed either drug can be choosen for the sedation in pediatric EEG recordings.